Diabetic retinopathy (DR) is the most common microangiopathic complication of diabetes
mellitus, representing a major cause of visual impairment in developed countries …

The human epidermal growth factor receptor (EGFR) family consists of four members that
belong to the ErbB lineage of proteins (ErbB1–4). These receptors consist of a glycosylated …

Currently, the treatment for ocular neovascular diseases, including diabetic macular edema
(DME) and age-related macular degeneration (AMD), mainly involves repeated intravitreal …

Background Human epidermal growth factor receptor (EGFR) is an oncogenic gene and one
of top targets of precision therapy in lung cancer with EGFR mutations. Although there are …

Bevacizumab (BCZ) is a recombinant humanized monoclonal antibody against the vascular
endothelial growth factor, which is involved in the angiogenesis process. Pathologic …

Diabetic Retinopathy (DR) is an expanding metabolic complications of diabetes mellitus
(DM) and is the leading cause of blindness in the working population. This disease occurs …

The management of exudative retinal diseases underwent a revolution due to the
introduction of intravitreal treatments. There are two main classes of intravitreal drugs …

Mutations in the RNaseH2A gene are involved in Aicardi‑Goutieres syndrome, an autosomal
recessive neurological dysfunction; however, studies assessing RNaseH2A in relation to …

Abstract Epithelial membrane protein 2 (EMP2) is a cell surface protein that has recently
emerged as an object of neuro-oncological interest due to its potential to be utilized as a …

Glioblastoma multiforme (GBM) is the most common adult primary tumor of the central
nervous system. The current standard of care for glioblastoma patients involves a …